People: MIT Chemistry Professor Sharpless Assumes Scripps Clinic's New W.M. Keck Chair

The Scripps Clinic and Research Foundation in La Jolla, Calif. has announced the appointment of K. Barry Sharpless to the new W.M. Keck Foundation Chair in Chemistry. The position was created earlier this year with a $2.9 million award from the Los Angeles-based Keck Foundation. Sharpless, a chemist and expert in asymmetric synthesis and metal-based catalysis, is currently the Arthur C. Cope Professor of Chemistry at the Massachusetts Institute of Technology. He will begin in his new post at S

Written byJulia King
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Scripps Clinic and Research Foundation in La Jolla, Calif. has announced the appointment of K. Barry Sharpless to the new W.M. Keck Foundation Chair in Chemistry. The position was created earlier this year with a $2.9 million award from the Los Angeles-based Keck Foundation.

Sharpless, a chemist and expert in asymmetric synthesis and metal-based catalysis, is currently the Arthur C. Cope Professor of Chemistry at the Massachusetts Institute of Technology. He will begin in his new post at Scripps in the spring of next year. Once there, he and his team of about 15 researchers will join four other senior Scripps faculty members in research on the design and synthesis of molecules to combat disease. The research project will include the synthesis of biologically active natural compounds as well as synthetic derivatives that have potential medical applications in allergy, diabetes, arthritis, heart disease, Alzheimer's disease, stroke, cancer, and viral ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies